Irvine, California-based Masimo says it designed its Freedom smartwatch to “revolutionize the wearable technology industry.” Along with continuous health tracking, it features novel hardware for reducing radiation and freeing users from privacy infringement.
The company said in a news release that the technology builds upon the Masimo W1 advanced biosensing watch. Freedom leverages a state-of-the-art sensor and digital signal processing technology. It provides continuous, accurate, and reliable readings of key health data. That includes arterial blood oxygen saturation (SpO2), hydration index (Hi), pulse rate, heart rate and respiration rate.
Freedom integrates Masimo’s health-tracking technology with Bluetooth, Wi-Fi and LTE connectivity. This enables the everyday conveniences of texting, calling, music and third-party app compatibility. Masimo Freedom also features a physical privacy switch that instantly stops all sharing data beyond the device. That includes user data, as well as microphone, location, and metadata.
“We believe that this groundbreaking new product will revolutionize wearable technology and health tracking,” said Masimo founder and CEO Joe Kiani. “We are allowing people to take control of their health with continuous and accurate actionable biosensing information along with the convenience of being connected, but without compromising their freedom.”
More about the Masimo Freedom
Masimo Freedom also utilizes technology based on Masimo SET pulse oximetry. It optimizes the capture of health data from the wrist.
The company also intends to introduce a sleek, screenless band built on innovations for W1 and Freedom. Masimo designed the band to work in tandem and synchronize with Freedom, allowing a user to wear one while charging the other. This creates a 24/7 continuous wear ecosystem, maximizing health tracking abilities all day.
Masimo said consumers can pre-order Freedom now with a fully refundable $100 deposit. It expects shipping to begin this fall, while shipping for W1 remains underway. Masimo also expects to have its band ready for sale this summer.
The company continues to make waves in the health monitoring space. In January, it extended a partnership with Philips to augment patient monitoring capabilities at home with W1. The advanced health-tracking watch first launched to early adopters in May 2022. It holds CE mark approval while FDA clearance is pending.
This system represents part of Masimo’s recently announced plan to turn home entertainment systems into health hubs.
